BCAB Stock Price
$1.51 (+1.00%)
At 2024-05-30 20:00:00 ESTBioAtla, Inc
(NASDAQ:BCAB) 
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small c...
Website: https://www.bioatla.com/
Founded: 2007
Sector: Healthcare
Industry: Biotechnology
Next Earnings Date: 2023-08-14
Share this website to your friends
BCAB - Daily
Date: 2024-05-31, O: 1.57, H: 1.63, L: 1.38, C: 1.51, Volume: 871,611
10EMA: 1.9220EMA: 2.2450EMA: 2.52100EMA: 2.51200EMA: 2.33
10EMA: 1.9220EMA: 2.2450EMA: 2.52100EMA: 2.51200EMA: 2.33
NASDAQ:BCAB Stock Key Statistics
| Basic Info: | |||
| Market Cap: | 69.40M | Exchange: | NASDAQ |
| Shares Outstanding: | 48,096,700 | Number of Employees: | |
| Advanced Info: | |||
| Beta: | 1.063 | Return on Equity (ROE) ttm: | -98.40% |
| Return on Assets (ROA) ttm: | -46.90% | Earnings per Share (EPS) ttm: | -2.58 |
| Book value per Share: | 1.47 | Cash per Share: | 2.72 |
| Current ast per Share: | 2.84 | ||
| Key Ratios: | |||
| P/E ttm: | P/E forward: | ||
| P/E ttm high: | P/E ttm low: | ||
| P/S ttm: | P/B ttm: | 1.02 | |
| P/FCF ttm: | -0.65 | PEG ratio: | |
| Cash Ratios: | |||
| Cash Ratio ttm: | 3.93 | Quick Ratio ttm: | 3.93 |
| Current Ratio ttm: | 4.11 | ||
| Margins: | |||
| Gross Margin ttm: | EBITDA Margin ttm: | ||
| Operating Margin ttm: | Net Income Margin ttm: | ||
| Dividends: | |||
| Trailing Dividend yield: | Forward Dividend yield: | ||
| Payout Ratio ttm: | Ex-Dividend date: | None | |
| Target Prices: | |||
| Target Price High: | 25 USD | Target Price Low: | 8 USD |
| Target Price Mean: | 15 USD | Number of Analysts: | 6 |
| Debt: | |||
| Debt Ratio ttm: | 0.02 | Debt to Equity ttm: | 0.03 |
| Total Net Debt: | -109.01M | ||
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.